AI-powered portable sensor enables rapid and multiplexed cardiac biomarker testing
The Californer/10343716

LOS ANGELES - Californer -- Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 20 million deaths each year. Rapid diagnosis and risk assessment of cardiac injury are therefore essential for improving patient outcomes. In clinical practice, physicians often rely on cardiac biomarker measurements; for example, troponin I (cTnI) and CK-MB are commonly used to diagnose myocardial infarction (heart attack), and NT-proBNP is a gold-standard biomarker for heart failure. Because heart attack and heart failure are often interrelated, clinicians increasingly rely on multiplexed biomarker testing for a more precise risk stratification and earlier intervention. However, such multiplexed testing is currently performed using large, expensive centralized laboratory analyzers, limiting its availability in decentralized and time-critical settings.

To address this challenge, UCLA researchers developed a dual-mode multiplexed vertical flow assay (xVFA) platform capable of detecting multiple cardiac biomarkers in a compact point-of-care format. Recently published in Light: Science & Applications, a journal of Springer Nature, this work demonstrates that combining colorimetric and chemiluminescent biosensing within a single paper-based test, together with neural network-based signal analysis, enables accurate multiplexed detection of three key cardiac markers (cTnI, CK-MB, and NT-proBNP) across clinically relevant concentration ranges, improving point-of-care diagnostics.

More on The Californer

• ATOMS AI Launches Adrian: AI Ads Agent That Automates Google Campaigns from Creation to Conversion
• Food Journal Magazine Unveils Its Latest 'Best of Los Angeles' Culinary Discoveries
• Boston Industrial Solutions Launches Natron® 717S Series: A New Flexible UV LED Ink for Ricoh GH2220 Printheads
• California's servicemembers seize $11.4 million in deadly fentanyl so far this year
• TFC take-back project advances in California: 30,525 lbs of footwear now with circular innovators

This new platform benefits from two complementary optical modalities, namely colorimetry and chemiluminescence, integrated within a single paper-based cartridge. Colorimetric sensing provides reliable signal detection at higher biomarker concentrations, while chemiluminescence enables highly sensitive detection of extremely low biomarker levels. By combining these two sensing modes in a single assay, the system can accurately quantify cardiac biomarkers across a much broader dynamic range than conventional rapid tests.

The dual-mode xVFA system operates through a streamlined workflow by loading 50 µL of serum sample into a multiplexed paper-based cartridge, enabling easy operation by minimally trained medical personnel. The cartridge contains multiple testing spots coated with antibodies specific to the three target biomarkers, providing parallel detection within a single test. After the operation, the system generates both colorimetric and chemiluminescent optical signals, which are captured by a portable optical reader. These signals are then rapidly analyzed using a neural network-based algorithm that interprets the multiplexed sensor responses and accurately predicts biomarker concentrations. The sensor provides quantitative results for three cardiac biomarkers – cTnI, CK-MB, and NT-proBNP – in just 23 minutes, all in a single test, to support rapid clinical decision-making.

More on The Californer

• Long Beach Public Works to Host Community Meeting on 10th Street Greenbelt Project
• California expands mobile driver's license to Samsung Wallet, continuing DMV's digital transformation 
• Long Beach Youth Poets Take the Stage: 2026 Youth Poet Laureate Finals Set for May 16
• California: First Partner Jennifer Siebel Newsom highlights new program preparing CSU Northridge students for careers and entrepreneurship
• California: La Primera Pareja Jennifer Siebel Newsom destaca nuevo programa que prepara a estudiantes de CSU Northridge para carreras profesionales y el emprendimiento

UCLA researchers rigorously validated the system using patient serum samples, demonstrating strong agreement with conventional laboratory-based measurements. In particular, neural network models trained and blindly tested in this study yielded robust quantification performance for the three cardiac biomarkers.

See the article: https://www.nature.com/articles/s41377-026-02275-9